Surgical Conditions During Laparoscopic Bariatric Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

October 31, 2017

Conditions
Morbid Obesity
Interventions
DRUG

Rocuronium

Rocuronium will be administered to achieve either a moderate (2-3 twitches) or deep (0-1 posttetanic) block depending on the group assignment

DEVICE

Insufflation pressure

The initial insufflation pressure will be set at either 10 or 15 mm Hg depending on the group assignment

Trial Locations (1)

65212

University Hospital, Columbia

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Missouri-Columbia

OTHER

NCT02703909 - Surgical Conditions During Laparoscopic Bariatric Surgery | Biotech Hunter | Biotech Hunter